Saturday, 3 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleUk· January 22, 2026

Trump sues ‘woke’ JP Morgan for $5bn over debanking

View original at uk.finance.yahoo.com
Trump sues ‘woke’ JP Morgan for $5bn over debanking Donald Trump is suing JP Morgan and its chief executive, Jamie Dimon. - Krisztian Bocsi/Bloomberg Donald Trump is suing JP Morgan and its chief executive Jamie Dimon for $5bn (£3.7bn) over claims it debanked him…
Opening lines of the source · Uk · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • In 5 years AI will be smarter than all of humanity collectively

    80% confidence
  • Truss-Kwarteng Budget lesson is they did not propose to cut spending

    80% confidence
  • Trump's 10% credit card fee cap would be disaster

    80% confidence
  • If European countries sell US debt in response to tariff threats there would be big retaliation on US part because we have all the cards

    80% confidence
  • I have a lot of friends who are Democrats, and they're idiots...big hearts and little brains...Almost every single policy rolled out failed

    80% confidence
  • Any threat to acquire European territory by force would be unacceptable and new tariffs would undermine foundations of transatlantic relations

    80% confidence
  • If there's a big consensual view, take opposite trade position

    80% confidence
  • Limiting factor for AI deployment is fundamentally electrical power

    80% confidence
  • SpaceX refuellable rockets will bring space travel cost below $100 per pound

    80% confidence
  • US would not use military force on Greenland

    80% confidence
  • Geopolitical temperature eased a few degrees

    80% confidence
  • Solar in space 5x more effective than ground: always sunny, no day-night cycle, no seasonality/weather, 30% more power

    80% confidence
  • UK would not yield over Greenland

    80% confidence
  • Trump lawsuit has no merit

    80% confidence
  • AI will be smarter than any human by end of next year (2027)

    80% confidence
  • Would be very, very surprised if countries sold US assets

    80% confidence
  • Tesla Robotaxis will be very widespread by end of this year

    80% confidence
  • JP Morgan needed to distance itself from President Trump and his conservative political views

    80% confidence
  • Stock market went up very substantially after Greenland deal announced

    80% confidence
  • US insurers halving premiums for customers with Tesla software

    80% confidence
  • AI growth limited by ability to create energy to power it

    80% confidence
  • Tesla robots will do more complex tasks in factories by end of this year

    80% confidence
  • Hoped we are now in a much better place to focus on Arctic security

    80% confidence
  • Tesla hopes for supervised full self-driving approval in Europe hopefully next month, similar timing for China

    80% confidence
  • Virtually no inflation and extraordinarily high economic growth in US

    80% confidence
  • Trump pulled a predictable U-turn

    80% confidence
  • I want an open economy, I need to trade with China

    80% confidence
  • Trump's policies are a rupture, old order is dead, heading to world without rules

    80% confidence
  • Trump's attacks on Fed Chairman Jerome Powell threaten inflation

    80% confidence
  • Self-driving cars are a solved problem

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com